These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
240 related items for PubMed ID: 11164425
1. The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding. de Man FH, de Beer F, van der Laarse A, Jansen H, Leuven JA, Souverijn JH, Vroom TF, Schoormans SC, Fruchart JC, Havekes LM, Smelt AH. Atherosclerosis; 2000 Dec; 153(2):363-71. PubMed ID: 11164425 [Abstract] [Full Text] [Related]
4. Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia. Huang Y, Liu XQ, Rall SC, Taylor JM, von Eckardstein A, Assmann G, Mahley RW. J Biol Chem; 1998 Oct 09; 273(41):26388-93. PubMed ID: 9756870 [Abstract] [Full Text] [Related]
5. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL. Murdoch SJ, Breckenridge WC. Atherosclerosis; 1995 Dec 09; 118(2):193-212. PubMed ID: 8770314 [Abstract] [Full Text] [Related]
6. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E. Dergunov AD, Smirnova EA, Merched A, Visvikis S, Siest G, Yakushkin VV, Tsibulsky V. Biochim Biophys Acta; 2000 Feb 24; 1484(1):29-40. PubMed ID: 10685028 [Abstract] [Full Text] [Related]
7. Effect of apolipoprotein E variants on lipolysis of very low density lipoproteins by heparan sulphate proteoglycan-bound lipoprotein lipase. de Man FH, de Beer F, van de Laarse A, Smelt AH, Leuven JA, Havekes LM. Atherosclerosis; 1998 Feb 24; 136(2):255-62. PubMed ID: 9543096 [Abstract] [Full Text] [Related]
8. Effects of gemfibrozil on very-low-density lipoprotein composition and low-density lipoprotein size in patients with hypertriglyceridemia or combined hyperlipidemia. Yang CY, Gu ZW, Xie YH, Valentinova NV, Yang M, Yeshurun D, Quion JA, Gotto AM. Atherosclerosis; 1996 Sep 27; 126(1):105-16. PubMed ID: 8879439 [Abstract] [Full Text] [Related]
9. Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III. Sun HY, Lin CC, Lee JC, Wang SW, Cheng PN, Wu IC, Chang TT, Lai MD, Shieh DB, Young KC. Gut; 2013 Aug 27; 62(8):1193-203. PubMed ID: 22689516 [Abstract] [Full Text] [Related]
10. Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase. Mulder M, Lombardi P, Jansen H, van Berkel TJ, Frants RR, Havekes LM. J Biol Chem; 1993 May 05; 268(13):9369-75. PubMed ID: 8387492 [Abstract] [Full Text] [Related]
11. Uptake of hypertriglyceridemic very low density lipoproteins and their remnants by HepG2 cells: the role of lipoprotein lipase, hepatic triglyceride lipase, and cell surface proteoglycans. Huff MW, Miller DB, Wolfe BM, Connelly PW, Sawyez CG. J Lipid Res; 1997 Jul 05; 38(7):1318-33. PubMed ID: 9254059 [Abstract] [Full Text] [Related]
12. Uptake of type IV hypertriglyceridemic VLDL by cultured macrophages is enhanced by interferon-gamma. Whitman SC, Argmann CA, Sawyez CG, Miller DB, Hegele RA, Huff MW. J Lipid Res; 1999 Jun 05; 40(6):1017-28. PubMed ID: 10357833 [Abstract] [Full Text] [Related]
13. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase. Chung BH, Segrest JP, Franklin F. Atherosclerosis; 1998 Dec 05; 141(2):209-25. PubMed ID: 9862170 [Abstract] [Full Text] [Related]
14. Lipoprotein lipase binds to low density lipoprotein receptors and induces receptor-mediated catabolism of very low density lipoproteins in vitro. Medh JD, Bowen SL, Fry GL, Ruben S, Andracki M, Inoue I, Lalouel JM, Strickland DK, Chappell DA. J Biol Chem; 1996 Jul 19; 271(29):17073-80. PubMed ID: 8663292 [Abstract] [Full Text] [Related]
15. Very-low-density lipoprotein-induced triglyceride accumulation in human mesangial cells is mainly mediated by lipoprotein lipase. Li J, Li H, Wen YB, Li XW. Nephron Physiol; 2008 Jul 19; 110(1):p1-10. PubMed ID: 18698144 [Abstract] [Full Text] [Related]
16. Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment. Eisenberg S, Gavish D, Oschry Y, Fainaru M, Deckelbaum RJ. J Clin Invest; 1984 Aug 19; 74(2):470-82. PubMed ID: 6378975 [Abstract] [Full Text] [Related]
17. Lipolysis-induced partitioning of free fatty acids to lipoproteins: effect on the biological properties of free fatty acids. Chung BH, Tallis GA, Cho BH, Segrest JP, Henkin Y. J Lipid Res; 1995 Sep 19; 36(9):1956-70. PubMed ID: 8558084 [Abstract] [Full Text] [Related]
18. Lipolysis is a prerequisite for lipid accumulation in HepG2 cells induced by large hypertriglyceridemic very low density lipoproteins. Evans AJ, Sawyez CG, Wolfe BM, Huff MW. J Biol Chem; 1992 May 25; 267(15):10743-51. PubMed ID: 1587849 [Abstract] [Full Text] [Related]
19. Structure-function relationship of lipoprotein lipase-mediated enhancement of very low density lipoprotein binding and catabolism by the low density lipoprotein receptor. Functional importance of a properly folded surface loop covering the catalytic center. Salinelli S, Lo JY, Mims MP, Zsigmond E, Smith LC, Chan L. J Biol Chem; 1996 Sep 06; 271(36):21906-13. PubMed ID: 8702993 [Abstract] [Full Text] [Related]
20. Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia. Saku K, Sasaki J, Arakawa K. Clin Ther; 1989 Sep 06; 11(3):331-40. PubMed ID: 2743372 [Abstract] [Full Text] [Related] Page: [Next] [New Search]